Lunai Bioworks (LNAI) Other Non-Current Liabilities (2012 - 2025)
Lunai Bioworks (LNAI) recorded quarterly Other Non-Current Liabilities of $271643.0 in Q2 2025, up 17.4% quarter-over-quarter from $231381.0 in Q2 2024, and up 17.4% on a YoY basis from $231381.0 in Q2 2024.
Lunai Bioworks (LNAI) Other Non-Current Liabilities (2012 - 2025) Analysis & Trends
Lunai Bioworks' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $271643.0 for Q2 2025.
- In Q2 2025, Other Non-Current Liabilities rose 17.4% year-over-year to $271643.0; the TTM figure through Jun 2025 stood at $271643.0 (up 17.4% YoY), while the FY2025 annual figure was $271643.0, up 17.4% from the prior year.
- Other Non-Current Liabilities was $271643.0 for Q2 2025 at Lunai Bioworks, up from $231381.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $19.1 million in Q1 2024 to a low of $166625.0 in Q2 2022.
- Historically, Other Non-Current Liabilities has averaged $6.3 million across 4 years, with a median of $6.0 million in 2021.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 336.41% in 2021, then tumbled 97.24% in 2022.
- A 4-year view of Other Non-Current Liabilities shows it stood at $9.0 million in 2021, then plunged by 98.15% to $166625.0 in 2022, then jumped by 38.86% to $231381.0 in 2024, then increased by 17.4% to $271643.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $271643.0 (Q2 2025), $231381.0 (Q2 2024), and $19.1 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 271,643.00 |
| Jun 30, 2024 | 231,381.00 |
| Mar 31, 2024 | 19.06 Mn |
| Jun 30, 2022 | 166,625.00 |
| Mar 31, 2022 | 10.31 Mn |
| Dec 31, 2021 | 9.03 Mn |
| Sep 30, 2021 | 8.86 Mn |
| Jun 30, 2021 | 6.04 Mn |
| Mar 31, 2021 | 2.95 Mn |
| Dec 31, 2020 | 2.07 Mn |
| Sep 30, 2020 | 2.76 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.01 Mn |
| Dec 31, 2019 | 4.32 Mn |
| Sep 30, 2019 | 5.40 Mn |
| Jun 30, 2019 | 5.67 Mn |
| Jun 30, 2018 | 22.89 Mn |
| Dec 31, 2012 | 850,753.00 |